invigor semaglutide Weight loss medication and heart health Ozempic Maker Novo Nordisk Beats

Momentum is high right now, Dr

Programme-based providers assign you a named coach

Telehealth can give health and wellness providers a unique opportunity to meet patients and clients in a more private, one-on-one setting, helping reduce stigma while building trust through compassionate, convenient care

BDNF, brain-derived neutrophic factors

Personalized plans based on your health history and weight loss goals Physician-supervised care with ongoing monitoring and follow-up Telehealth consultations from anywhere in Pennsylvania no office visit required GLP-1 and GIP prescription medications when clinically appropriate The STEP-1 clinical trial found that semaglutide produced an average weight loss of 12-15% of body weight over 68 weeks in patients with obesity a clinically significant result particularly relevant in Pennsylvania, where approximately 34.4% of adults are affected by obesity according to the CDC